SLShanshan Li

Shanshan Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shanshan Li has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clock-Related Genes Mark a Developmental Cortical Maturation Program Associated with Stage-Resolved Responses to Prenatal Immune Activation

    by Yilin Wang, Shanshan Li, Xin Jin

    Background/Objectives: Sleep and circadian disturbances are common in neurodevelopmental conditions, yet the developmental cortical programs linking clock-related transcriptional regulators to disease vulnerability remain unclear. Methods: Here, we integrated human developmental brain transcriptomes, weighted gene co-expression network analysis (WGCNA), human and mouse cortical single-cell atlases, prenatal immune activation transcriptomes, and ASD postmortem brain datasets to characterize the developmental architecture of BrainSpan-derived cortical programs and examine their behavior in perturbational and disease contexts. Results: In the BrainSpan frontal cortex, canonical clock-related genes followed structured but heterogeneous developmental trajectories rather than behaving as a coordinated oscillator-like unit. WGCNA identified a postnatal-rising BrainSpan-derived primary developmental module that was strongly associated with developmental age and enriched for synaptic signaling, neurotransmitter transport, ion transport, membrane excitability, cellular respiration, metabolic regulation, and proteostatic processes. Network analysis placed multiple canonical clock-related and clock-regulatory genes, including NPAS2, BHLHE40, BHLHE41, PER family members, RORA, NR1D1/2, and CLOCK, within a broader neuronal and homeostatic co-expression architecture, although their module-membership strengths varied substantially. Projection onto a human cortical developmental single-cell atlas revealed a non-uniform distribution of the corrected BrainSpan-derived developmental signature, with relatively higher scores in excitatory and inhibitory neuronal populations and lower scores in neuroblast and radial glial populations. A mouse cortical developmental single-cell atlas provided a comparative view of the stage- and cell-type-dependent expression of clock-related genes and the transferred developmental signature during corticogenesis. In a Poly(I:C)-based maternal immune activation dataset, litter-aware reanalysis identified stage-resolved genome-wide transcriptional responses following E12.5 exposure. However, neither the aggregate core clock-gene expression score nor the independently transferred BrainSpan-derived developmental signature showed a significant overall treatment effect or collection-stage-by-treatment interaction, indicating that this bulk dataset provides a perturbational context rather than evidence for selective disruption of the developmental program. An exploratory region-stratified analysis of GSE28521 yielded near-null effects for the BrainSpan-derived developmental signature, with confidence intervals crossing zero across all examined regions. These ASD postmortem findings were therefore treated as a boundary assessment rather than evidence of ASD-specific convergence. Conclusions: Collectively, these findings position clock-related genes as components of a developmentally regulated cortical maturation program enriched for neuronal signaling, synaptic maturation, metabolic regulation, and stress-response processes.

  • Open Access

    Ion Channel Dysregulation in Neurodevelopmental Disorders: Mechanisms, Models, and Therapeutic Advances

    by Zihan Shi, Shanshan Li, Xin Jin

    Ion channels are fundamental to neuronal excitability, synaptic transmission, and the coordinated development of brain circuits. Disruptions in their function—collectively termed ion channelopathies—have emerged as central mechanisms underlying a broad spectrum of neurodevelopmental disorders (NDDs), including epilepsy, autism spectrum disorder, and intellectual disability. This review synthesizes current knowledge on the physiological roles of voltage-gated and ligand-gated ion channels during brain development and elucidates how their genetic and functional dysregulation contributes to disease pathogenesis. We examine key channel families, such as sodium, potassium, calcium, and glutamate/(gamma-aminobutyric acid) GABA receptors, as well as mechanosensitive and polymodal channels including transient receptor potential and Piezo channels, highlighting the molecular mechanisms, pathogenic variants, and circuit-level consequences of their dysfunction. Emerging therapeutic strategies are discussed, spanning subtype-specific small molecule modulators, antisense oligonucleotides, CRISPR-based genome editing, and patient-derived organoid models for precision medicine and drug screening. We also address significant challenges in the field, including cellular heterogeneity, developmental timing, and translational model fidelity. Together, these advances underscore a rapidly evolving landscape in which precision neurogenetics and integrative platforms hold promise for transforming the diagnosis and treatment of ion channel-related neurodevelopmental disorders.


  • Open Access

    From Transcriptome to Therapy: The ncRNA Revolution in Neurodevelopmental Disorders

    by Jiayi Zhao, Shanshan Li, Xin Jin

    Neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disability (ID) arise from disruptions of molecular programmes that coordinate neurogenesis, synaptogenesis, and circuit maturation. While genomic studies have identified numerous susceptibility loci, genetic variation alone accounts for only part of disease heritability, underscoring the importance of post-transcriptional and epigenetic regulation. Among these regulatory layers, non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), PIWI-interacting RNAs (piRNAs), and transfer RNA-derived small RNAs (tsRNAs), have emerged as central modulators of neural differentiation, synaptic plasticity, and intercellular signalling. Recent multi-omics and single-cell studies reveal that ncRNAs fine-tune chromatin accessibility, transcriptional output, and translation through tightly integrated regulatory networks. miRNAs shape neurogenic transitions and circuit refinement; lncRNAs and circRNAs couple chromatin architecture to activity-dependent transcription; and tsRNAs and piRNAs extend this regulation by linking translational control to epigenetic memory and environmental responsiveness. Spatial transcriptomics further maps ncRNA expression to vulnerable neuronal and glial subtypes across cortical and subcortical regions. Clinically, circulating ncRNAs, especially those packaged in extracellular vesicles, exhibit stable, disease-associated signatures, supporting their potential as minimally invasive biomarkers for early diagnosis and patient stratification. Parallel advances in RNA interference, antisense oligonucleotides, CRISPR-based editing, and vesicle-mediated delivery highlight emerging therapeutic opportunities. These developments position ncRNAs as both mechanistic determinants and translational targets in NDDs, offering a unifying framework that links genome regulation, environmental cues, and neural plasticity, and paving the way for next-generation RNA-guided diagnostics and therapeutics.


  • Open Access

    From Transcriptome to Therapy: The ncRNA Revolution in Neurodevelopmental Disorders

    by Jiayi Zhao, Shanshan Li, Xin Jin

    Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD) and intellectual disability (ID), arise from disruptions of tightly orchestrated molecular programmes that govern neurogenesis, synaptogenesis and circuit maturation. Although large-scale genomic analyses have identified numerous susceptibility loci, DNA variation alone explains only a fraction of disease heritability, highlighting the pivotal contribution of post-transcriptional and epigenetic regulation. Among these regulatory layers, non-coding RNAs (ncRNAs)—encompassing microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), PIWI-interacting RNAs (piRNAs) and transfer-RNA-derived small RNAs (tsRNAs)—have emerged as key modulators of neural differentiation, synaptic plasticity and intercellular communication. Multi-omics studies reveal that ncRNAs fine-tune chromatin accessibility, transcriptional output and translation through complex competing-endogenous-RNA (ceRNA) and ribonucleoprotein networks. While miRNAs sculpt neurogenesis and circuit remodelling, lncRNAs and circRNAs integrate chromatin and transcriptional control with exquisite spatial and temporal precision. Newly characterized small RNAs such as tsRNAs and piRNAs extend this regulatory repertoire by linking translational reprogramming, epigenetic memory and even intergenerational inheritance. Advances in single-cell and spatial transcriptomics have further mapped ncRNA expression to discrete neuronal and glial populations, revealing cell-type-specific vulnerability signatures across cortical and subcortical regions. Clinically, circulating ncRNAs—particularly those encapsulated within plasma or extracellular vesicles—exhibit robust and disease-specific expression patterns, supporting their promise as non-invasive biomarkers for early diagnosis and patient stratification. In parallel, innovations in RNA interference, antisense oligonucleotides, CRISPR-based editing and exosome-mediated delivery are transforming ncRNAs from molecular indicators into therapeutic instruments capable of restoring transcriptional and epigenetic equilibrium. Together, these converging insights position ncRNAs as both mechanistic determinants and translational targets in neurodevelopmental pathology. The emerging ncRNA landscape redefines the molecular architecture of brain development, offering a unifying framework that links genome regulation, environmental responsiveness and neural plasticity. Decoding this multilayered RNA circuitry will be pivotal for the development of next-generation diagnostics and RNA-guided therapies for neurodevelopmental disorders.

  • PIWI-Interacting RNAs in brain health and disease: biogenesis, mechanisms, and therapeutic horizons

    by Yuang Cai, Shaoyuan Huang, Yifan Dong, Shanshan Li, Xin Jin

    PIWI-interacting RNAs (piRNAs), a class of small non-coding RNAs originally identified for their role in transposon silencing in germ cells, have recently been recognized as pivotal regulators of gene expression in the central nervous system. Beyond their canonical functions in genome defense, emerging evidence highlights piRNAs as key modulators of neuronal development, synaptic plasticity, axonal regeneration, and neuroimmune interactions—processes central to brain function and dysfunction. This review provides a comprehensive overview of piRNA biogenesis, molecular mechanisms, and regulatory pathways relevant to neurobiology. We focus on the growing body of evidence implicating piRNA dysregulation in major neurological and neuropsychiatric disorders, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, stroke, glioma, autism spectrum disorder, and schizophrenia. Importantly, we discuss the neuropharmacological implications of piRNA pathways as novel targets for therapeutic intervention and their potential utility as biomarkers for early diagnosis and treatment stratification. By integrating mechanistic insights with emerging translational evidence, this review highlights piRNAs as promising molecular targets in the development of next-generation neurotherapeutics aimed at modifying disease progression and improving brain health.


  • Open Access

    PIWI‐interacting RNA MIABEPIR regulates cerebral endothelial cell function via DAPK2 pathway in offspring following maternal immune activation

    by Shan‐Shan Li, Miao Guo, Yao Long, Yuang Cai, Ying Zhao, Shaoyuan Huang, Houzhi Yang, Yonggang Fan, Xu Chen, Xin Jin

    Maternal immune activation (MIA) is recognised as a risk factor in the neurodevelopmental disorders. However, the precise molecular pathways through which MIA disrupts neurovascular function remain largely unexplored. Here, we identify a novel MIA‐associated brain endothelial piRNA (MIABEPIR) involved in regulating BMEC function and BBB integrity. RNA microarray analysis of foetal brain tissue from MIA‐exposed mice revealed significant changes in piRNA expression, including a marked upregulation of MIABEPIR upregulated piRNAs. Immunofluorescence and FISH confirmed that MIABEPIR is localised in the microvascular endothelial cells of the brain. MIABEPIR overexpression enhances BMEC proliferation and angiogenesis but disrupts BBB integrity. In vivo, intracranial administration of lentiviral MIABEPIR in foetal mice resulted in marked BBB disruption. Mechanistically, we identified DAPK2 as a downstream target of MIABEPIR, leading to its downregulation. This suppression of DAPK2 inhibits autophagy in BMECs, suggesting that MIABEPIR modulates endothelial cell autophagy through the DAPK2 pathway. Our findings reveal a novel piRNA‐mediated regulatory mechanism in neurovascular function during MIA and highlight MIABEPIR's role in MIA‐induced neurodevelopmental abnormalities. Targeting the MIABEPIR‐DAPK2 axis represents a potential therapeutic strategy for addressing neurovascular dysfunction in neurodevelopmental disorders associated with maternal immune stress.


  • Protosappanin B activates the Wnt pathway to protect against glucocorticoid-induced osteoblast inhibition and enhance bone formation

    by Jigeng Fan, Yahui Wang, Houzhi Yang, Shaoyuan Huang, Yuan Ma, Jie Guo, YuTao Jia, Ying Zhang, Yonggang Fan, Donglun Xiao, et al.


  • 5,7-Dihydroxy-4-Methylcoumarin enhances osteogenesis and ameliorates osteoporosis via the AKT1 pathway

    by Han Diao, Houzhi Yang, Bin Yu, Yonggang Fan, Shenao Li, Jigeng Fan, Donglun Xiao, Ying Zhao, Miao Guo, Ying Zhang, et al.